Bell Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.36K | Buy |
201
+43
| +27% | +$933 | ﹤0.01% | 1045 |
|
|
2025
Q1 | $3.83K | Buy |
158
+23
| +17% | +$558 | ﹤0.01% | 1033 |
|
|
2024
Q4 | $2.82K | Buy |
135
+17
| +14% | +$355 | ﹤0.01% | 1196 |
|
|
2024
Q3 | $2.35K | Hold |
118
| – | – | ﹤0.01% | 1283 |
|
|
2024
Q2 | $1.83K | Hold |
118
| – | – | ﹤0.01% | 1387 |
|
|
2024
Q1 | $1.88K | Sell |
118
-43
| -27% | -$685 | ﹤0.01% | 1386 |
|
|
2023
Q4 | $2.71K | Sell |
161
-36
| -18% | -$605 | ﹤0.01% | 1199 |
|
|
2023
Q3 | $2.3K | Buy |
+197
| New | +$2.3K | ﹤0.01% | 1196 |
|
|
2023
Q2 | – | Sell |
-39
| Closed | -$647 | – | 1936 |
|
|
2023
Q1 | $647 | Hold |
39
| – | – | ﹤0.01% | 1704 |
|
|
2022
Q4 | $725 | Hold |
39
| – | – | ﹤0.01% | 1670 |
|
|
2022
Q3 | $1K | Buy |
+39
| New | +$1K | ﹤0.01% | 1361 |
|